$ANIP News Stocks to Watch Friday: Morgan Stanley 3:40

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ANIP News

Stocks to Watch Friday: Morgan Stanley 3:40 p.m. Oct. 4, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:24 p.m. Oct. 4, 2012 - MarketWatch
BioSante to merge with ANI in all-stock deal 9:56 a.m. Oct. 4, 2012 - MarketWatch.com

AMAG, Takeda Mutually End Agreement for Feraheme - Analyst Blog 6:30 p.m. Dec. 30, 2014 - Zacks.com
BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog 5:10 p.m. Dec. 30, 2014 - Zacks.com
Xenon Pharmaceuticals (XENE) Jumps: Stock Surges 16.8% - Tale of the Tape 9:11 a.m. Dec. 30, 2014 - Zacks.com
Commit To Buy ANI Pharmaceuticals At $50, Earn 21.5% Annualized Using Options 11:35 a.m. Dec. 29, 2014 - TheStreet.com
Actelion Submits New Drug Application for Uptravi in the U.S. - Analyst Blog 5:35 p.m. Dec. 23, 2014 - Zacks.com
Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog 3:50 p.m. Dec. 23, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog 1:40 p.m. Dec. 19, 2014 - Zacks.com
Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog 2:40 p.m. Dec. 18, 2014 - Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog 6:00 p.m. Dec. 16, 2014 - Zacks.com
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog 5:46 p.m. Dec. 16, 2014 - Zacks.com
Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog 2:30 p.m. Dec. 16, 2014 - Zacks.com
OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape 9:06 a.m. Dec. 16, 2014 - Zacks.com
BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape 9:02 a.m. Dec. 16, 2014 - Zacks.com
bluebird bio (BLUE) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:38 a.m. Dec. 16, 2014 - Zacks.com
One Stock Chart Trick You Should All Know - Investment Ideas 1:00 a.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape 9:46 a.m. Dec. 15, 2014 - Zacks.com


Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference 8:30 a.m. Dec. 11, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option 12:33 p.m. Dec. 10, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering 8:23 a.m. Dec. 5, 2014 - PR Newswire - PRF
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes 9:00 a.m. Dec. 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results 7:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire 3:30 p.m. Aug. 1, 2014 - PR Newswire - PRF
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Transdermal Drug Delivery Market 2014-2018 4:22 p.m. July 28, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 7:30 a.m. July 28, 2014 - PR Newswire - PRF
RestorGenex Announces Management Changes 6:00 a.m. July 9, 2014 - BusinessWire - BZX
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics 9:50 a.m. July 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd. 7:30 a.m. June 18, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen 8:00 a.m. May 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results 7:30 a.m. April 28, 2014 - PR Newswire - PRF
Upcoming Conference Calls, Commencement of Shipments, Stock Price Movements, Awareness Campaigns, and Acquisitions - Analyst Notes on Incyte, Impax, ANI, Ironwood and Aastrom 7:00 a.m. April 24, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Presents at 26th Annual ROTH Conference 4:00 p.m. March 10, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 0

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 0

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 0

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 0

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 0

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 0

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading

Top 5 Most Recently Viewed Articles

KinderFarms Introduces KinderMed: A Natural Solution for Kids

Updated Category News Views 258

KinderFarms Introduces KinderMed Pain & Fever Medicine KinderFarms, an innovative wellness brand dedicated to improving family health, has launched its latest product, KinderMed Pain & Fever. This over-the-counter medicine is designed specifically for infants and children, providing effective relief while upholding cleanliness and safety in its ingredients. KinderMed...

Continue Reading
Vietnam's Embedded Finance Sector Set for Explosive Growth

Updated Category News Views 117

The embedded finance landscape in Vietnam saw explosive growth, with projections in 2024 indicating an annual growth rate of 33.6%. This momentum hinted at a potential market value soaring to US$426.3 million shortly after, but traders and analysts knew this was just the tip of the iceberg; forecasts whispered of a staggering compound annual growth rate (CAGR) hitting...

Continue Reading
HH Global Welcomes Matt Strawn as Chief Growth Officer

Updated Category News Views 253

HH Global Welcomes Matt Strawn as Chief Growth Officer HH Global, recognized as a leading partner in responsible marketing activation, has announced an exciting new addition to its executive team with the appointment of Matt Strawn as Chief Growth Officer. This strategic move is aimed at propelling the company into its next era of innovation and accelerated global growth....

Continue Reading
Hingham Institution for Savings Announces Quarterly Dividend Payment

Updated Category News Views 153

Hingham Institution for Savings Announces Quarterly Dividend Hingham Institution for Savings (NASDAQ: HIFS), a historic bank founded in 1834, has made an important announcement regarding its financial management. Recently, the Board of Directors declared a regular quarterly cash dividend of $0.63 per share, demonstrating the bank's ongoing commitment to returning capital...

Continue Reading
Upcoming Earnings: Insights and Expectations for Key Companies

Updated Category News Views 206

Anticipated Earnings Reports As we look forward to the next earnings season, several companies are set to report their quarterly results. Notably, these reports provide insight into the companies' performance and market trends. Companies Reporting Before The Market Opens Deere & Co Deere (NYSE: DE) is expected to announce quarterly earnings of $3.88 per share, projecting...

Continue Reading